| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Illumina, Inc. (ILMN) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 29 sells. ILMN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.50M | $565.17M | - | |
| Dir | 2.83M | $456.78M | -669,596 | |
| CEO | 82.1K | $13.25M | - | |
| VP | 41.9K | $6.77M | - | |
| VP | 33.0K | $5.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2019 | Desouza Francis A | President And CEO | Sell | 3,000 | $282.95 | $848,854.00 | -0.9% | |
| Feb 1, 2019 | Dadswell Charles82 | SVP &General Counsel | Sell | 124 | $280.11 | $34,733.64 | -1.8% | |
| Feb 1, 2019 | Epstein Robert S | Director | Sale+OE | 1,000 | $280.11 | $280,110.00 | -23.5% | |
| Jan 23, 2019 | Flatley Jay T47 | Director | Sell | 3,300 | $303.53 | $1,001,649.00 | -1.0% | |
| Jan 9, 2019 | Flatley Jay T47 | Director | Sell | 3,300 | $296.20 | $977,460.00 | -1.0% | |
| Jan 2, 2019 | Desouza Francis A | President And CEO | Sell | 3,000 | $293.33 | $879,994.00 | -0.9% | |
| Jan 2, 2019 | Dadswell Charles82 | Sr VP &General Counsel | Sell | 124 | $294.71 | $36,544.04 | -1.7% | |
| Jan 2, 2019 | Epstein Robert S | Director | Sale+OE | 1,000 | $294.71 | $294,710.00 | -23.5% | |
| Jan 2, 2019 | Eastham Karin65 | Director | Sale+OE | 5,000 | $294.08 | $1,470,381.31 | -3.3% | |
| Dec 26, 2018 | Flatley Jay T47 | Director | Sell | 3,300 | $273.87 | $903,771.00 | -1.0% |